Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: tDCS for Cancer-Related Fatigue and Weakness [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial is evaluating transcranial direct current stimulation (tDCS) for cancer-related fatigue and weakness; the trial is currently NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kessler Foundation | Conditions: Cancer-related Fatigue, Neuromodulation | EARLY_Phase 1 | Status: NOT_YET_RECRUITING